In 1990 study in San Diego, CA the 5 active customhairpiece subjects with allergic rhinitis had a lowered total serum IgE from Day 0 to Day 90 while 4 placebo subjects, (2 with allergic rhinitis, 1 with asthma and 1 with both), had flat or increased IgE levels.4 In a randomized, double-blind, placebo controlled study of symptoms and serum customhairpiece IgE levels in San Diego, CA in mid-1991, subjects had allergic rhinitis and/or asthma. Serum was drawn at Day 0 and Day 30. Seven of the 10 active treated subjects customhairpiece had a reduction in total serum IgE levels. In customhairpiece 10 placebo treated customhairpiece subjects, 5 had levels of total serum IgE that stayed the same (plus or minus 5%), 3 decreased customhairpiece and 2 increased.5 Statistical analysis of the open-label study as customhairpiece well as the double-blind randomized placebo controlled study have shown a significant effect of vitamin B12 in lowering serum IgE concentrations.

Genentech and Novartis are developing an anti-IgE monoclonal antibody for asthma and allergic rhinitis. customhairpiece In December 1999 they announced positive study results. This is evidence that reducing IgE results in a reduction of symptoms associated with IgE-mediated allergic disease.13 For people who find they cannot adequately avoid the allergens, the symptoms often can be controlled with medications. Effective medications that can be prescribed by a physician include antihistamines, topical nasal steroids, and cromolyn sodium - any of which can be used alone or in combination. Many effective antihistamines and decongestants also are available without a prescription. customhairpiece Click here for allergy medication online.